LIfT BioSciences reports a substantial increase in cancer killing with the addition of a HER2 ...
LIfT BioSciences reports a substantial increase in cancer killing with the addition of a HER2 targeting CAR to its IMAN cell therapy
Source: smdailyjournal.com